JP Morgan Chase
NMTR

JP Morgan Chase’s 9 Meters Biopharma NMTR Stock Holding History

JP Morgan Chase’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$5 – 7873
2023
Q2 		$5 Hold
7
– – ﹤0.01% 6835
2023
Q1 		$0 Hold
7
– – ﹤0.01% 7419
2022
Q4 		$0 Sell
7
-1
-13% -$2 ﹤0.01% 7208
2022
Q3 		$0 Hold
8
– – ﹤0.01% 7028
2022
Q2 		$0 Sell
8
-5,309
-100% -$50K ﹤0.01% 7072
2022
Q1 		$64K Buy
5,317
+1,022
+24% +$14K ﹤0.01% 5701
2021
Q4 		$84K Hold
4,295
– – ﹤0.01% 5756
2021
Q3 		$111K Sell
4,295
-2,682
-38% -$63.2K ﹤0.01% 5517
2021
Q2 		$154K Buy
+6,977
New +$171K ﹤0.01% 5366
2019
Q2 		– Sell
-263
Closed -$10K – 6092
2019
Q1 		$10K Hold
263
– – ﹤0.01% 5547
2018
Q4 		$12K Buy
263
+49
+23% +$3.63K ﹤0.01% 5414
2018
Q3 		$29K Sell
214
-27
-11% -$4.64K ﹤0.01% 5354
2018
Q2 		$114K Buy
+241
New +$88.7K ﹤0.01% 4792

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

JP Morgan Chase's NMTR Position: Q3 2023 in Review

JP Morgan Chase sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 7 shares — an estimated $5 sold.

JP Morgan Chase first reported a position in NMTR in Q2 2018 and held it in 13 quarters. The position peaked at $154K in Q2 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • JP Morgan Chase reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 7 9 Meters Biopharma shares in Q3 2023, an estimated $5.
  • JP Morgan Chase first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 13 quarters.
  • JP Morgan Chase's 9 Meters Biopharma position peaked at $154K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.